BiotechTube

Benign Prostatic Hyperplasia

7 competing products in clinical development for Benign Prostatic Hyperplasia.

Pipeline by Phase

Phase 33
Approved4

All Products (7)

ProductCompanyStageStatusHype
Tadalafil + Placebo + Alpha1 BlockerEli LillyApprovedCompleted
43
Mirabegron + Placebo + Tamsulosin HydrochlorideAstellas PharmaApprovedCompleted
43
Tamsulosin hydrochloride + Solifenacin succinateAstellas PharmaApprovedCompleted
43
Tamsulosin OCAS + PlaceboAstellas PharmaApprovedCompleted
43
Tadalafil + PlaceboEli LillyPhase 3Completed
40
Placebo + tadalafilEli LillyPhase 3Completed
40
Placebo tamsulosin hydrochloride OCAS 0.4 mg + Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg + Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg + tamsulosin hydrochloride OCAS 0.4 mg + tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) + tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg)Astellas PharmaPhase 3Completed
40